Schedule 13G ownership disclosure

NGM BIOPHARMACEUTICALS INC

Security class unavailable · CUSIP: 62921N105

Event date: 2022-10-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,435,518
Percent of class
8.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-22-000572
Form type
SC 13G
Filer
EcoR1 Capital, LLC
CIK
CIK 1587114
Filed
Oct 28, 2022
Reporting period
Oct 18, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub